22/05 – Thursday – Room 1 – Adults – clinical track | |
08:00 – 08:20 | Opening session |
08:20 – 08:50 | Plenary lecture: Preventing, identifying, and managing sepsis in the community: research and clinical priorities |
08:50 – 10:20 | Thematic session : ‘Primary’ prevention – stopping sepsis occuring in the first place |
08:50 – 09:05 | One health: a growing concept |
09:05 – 09:20 | Can we modify the social determinants of health that influence the incidence (and outcome) of sepsis? |
09:20 – 9:35 | Can we prevent hospital-acquired sepsis with quality improvement? |
9:35 – 9:50 | Does anti-microbial resistance worsen the incidence or outcome of sepsis, and can we modify it? |
9:50 – 10:20 | Discussion |
10:20 – 10:30 | Interview : where are we with ‘fixing’ sepsis? |
10:30 – 11:00 | BREAK |
11:00 – 12:30 | Thematic session : ‘Secondary’ prevention – finding (and treating) sepsis before the patient is too sick |
11:00 – 11:15 | Lessons learned from pre-hospital systems to prevent or mitigate acute cardiac events |
11:15 – 11:30 | Where are we with ED and (non-ICU) hospital-based early sepsis detection and intervention programs? |
11:30 – 11:45 | Where are we with ICU-based early sepsis detection and intervention programs? |
11:45 – 12:00 | The future of sepsis detection and early warning systems |
12:00 – 12:30 | Discussion |
12:30 – 14:00 | LUNCH |
12:30 – 13:30 | Sponsors symposium |
14:00 – 14:45 | Round table : Diagnostic stewardship: How do to it better? |
14:45 – 16:00 | PRO-CON: Do we need more resuscitation studies in sepsis? |
14:45 – 15:00 | No, we just need to apply what we already know |
15:00 – 15:15 | Yes, we do not know what to do |
15:15 – 15:30 | Discussion |
15:30 – 16:15 | PRO-CON Do sepsis protocols improve antibiotic stewardship? |
15:30 – 15:45 | No, they just promote excess antibiotic use (and worse AMR) |
15:45 – 16:00 | Yes, they improve patient outcomes and reduce AMR |
16:00 – 16:15 | Discussion |
16:15 – 16:45 | BREAK |
16:45 – 1800 | Thematic session : The patient looks septic: what should you do first? And second? |
16:45 – 17:00 | Initial resuscitation in low resource settings |
17:00 – 17:15 | Is there a role for precision medicine ? |
17:15 – 17:30 | How early should we use vasopressin? |
17:30 – 17:45 | What’s the best way to determine severity of shock and adequacy or resuscitation? |
17:45 – 18:00 | Discussion |
18:00 – 18:30 | E-poster session |
18:00 – 18:30 | IQG Session |
22/05 – Thursday – Room 2 – Adults – clinical + multiprofessional track | |
08:20 – 08:50 | Conference: Making global ICU research democratic and inclusive |
08:50 – 10:20 | Thematic session: Implementing sepsis best practice guidelines |
08:50 – 09:05 | Barriers and solutions in private hospitals |
09:05 – 09:20 | Barriers and solutions in public hospitals |
09:20 – 09:35 | Action plans: how to get it right? |
09:35 – 09:50 | Alternative learning strategies |
09:50 – 10:15 | Discussion |
10:15 – 10:30 | Your question is my question |
10:30 – 11:00 | BREAK |
11:00 – 12:15 | Thematic session : Where are we going with clinical trials in sepsis? |
11:00 – 11:15 | Dealing with heterogeneity of treatment effect |
11:15 – 11:30 | Are plataform trials feasible in the global south? |
11:30 – 11:45 | What is the best way to randomize? |
11:45 – 12:00 | Is ‘live’ phenotyping possible in RCTs? |
12:00 – 12:30 | Discussion |
12:30 – 14:00 | LUNCH |
12:30 – 13:30 | Sponsors symposium |
14:00 – 15:00 | Round table : Ventilatory support: how can we do better? |
15:00 – 16:15 | Thematic session: Bugs, bugs, bugs … |
15:00 – 15:15 | Microbial landscape of Sepsis |
15:15 – 15:30 | Where are we in the great war of bugs vs humans? |
15:30 – 15:45 | Practice implications of BLING-3 |
15:45 – 16:00 | Therapeutic drug monitoring: is it all hype? |
16:00 – 16:15 | Discussion |
16:15 – 16:45 | BREAK |
16:45 – 17:05 | Clinical challenge: Monitoring a patient with septic shock |
17:05 – 18:00 | PRO-CON: Antimicrobial resistance: how to solve this challenge? |
17:05 – 17:20 | We need better antimicrobials! |
17:20 – 17:35 | We need better prevention strategies! |
17:35 – 18:00 | Discussion |
22/05 – Thursday – Room 3 – Pediatrics and translational science | |
08:30 – 09:00 | Conference: How to define immune dysregulation in sepsis |
09:00 – 10:30 | Thematic session : Immune dysregulation |
09:00 – 09:15 | What can we learn from single-cell analyses? |
09:15 – 09:30 | Trained immunity: Harnessing a potential double-edged sword in sepsis |
09:30 – 09:45 | What is the role of neutrophils and NETs? |
09:45 – 10:00 | What can we learn from proteomics? |
10:00 – 10:30 | Discussion |
10:30 – 11:00 | BREAK |
11:00 – 11:30 | Conference: Phoenix Sepsis Criteria – Is it an Advance? |
11:30 – 12:30 | Round table: New sepsis definition: global relevance and tradeoffs |
12:30 – 14:00 | LUNCH |
12:30 – 13:30 | Sponsors symposium |
14:00 – 14:30 | Conference: Phoenix Sepsis Criteria: How do we implement them at the bedside? |
14:30 – 15:00 | PRO-CON: Septic Shock Management I |
14:30 – 14:45 | Steroids for septic shock: what is the downside? |
14:45 – 15:00 | Steroids for septic shock: rarely meeded and likely harmful |
15:00 – 15:15 | Discussion |
15:15 – 16:00 | PRO-CON: Septic Shock Management II |
15:15 – 15:30 | Echocardiograms by POCUS should be standard |
15:30 – 15:45 | POCUS: Echocardiograms by non-cardiologist can be risk |
15:45 – 16:00 | Discussion |
16:00 – 16:15 | Interview: Pediatric Sepsis: Epidemiological Perspectives from Latin America, Spain, and Portugal |
16:15 – 16:45 | BREAK |
16:45 – 18:00 | Thematic session (pediatrics): Sepsis prevention, early detection and treatment |
16:45 – 17:00 | Effectiveness of vaccination in preventing sepsis |
17:00 – 17:15 | Sepsis Biomarkers: Clinical Insights and Applications |
17:15 – 17:30 | Fluids: How much, over what time, what type |
17:30 – 17:45 | Early use of vasopressors – update on feasibility study |
17:45 – 18:00 | Discussion |
23/05 – Friday -Room 1 – Adults – clinical track | |
08:30 – 09:00 | Conference : When should we have Sepsis-4, and what should it look like? |
09:00 – 10:30 | Thematic session : Shock persists after 24 hours: what next? |
09:00 – 09:15 | Precision medicine with longitudinal shock phenotypes |
09:15 – 09:30 | Echocardiography: beyond the basics (discuss uncoupling, LV outflow obstruction) |
09:30 – 09:45 | Deaccumulation of fluids |
09:45 – 10:00 | Modulating the dysregulated immune response |
10:00 – 10:30 | Discussion |
10:30 – 11:00 | BREAK |
11:00 – 12:30 | Thematic session : The shock is over: why is my patient … |
11:00 – 11:15 | Not awake? |
11:15 – 11:30 | Still requiring mechanical ventilation? |
11:30 – 11:45 | Not tolerating tube feeds? |
11:45 – 12:00 | Not making urine? |
12:00 – 12:30 | Discussion |
12:30 – 14:00 | LUNCH |
12:30 – 13:30 | Sponsors symposium |
14:00 – 14:25 | Challeging images: interactive session |
14:25 – 14:45 | Your question is my question |
14:45 – 15:45 | Round table : Improving survivorship from ED admission |
15:45 – 16:15 | Conference: AI-driven healthcare – promise and reality |
16:15 – 16:45 | BREAK |
16:45 – 18:15 | GRAND FINALE |
23/05 – Friday – Adults – clinical + multiprofessional track | |
08:30 – 09:00 | Plenary lecture: Re-examining the Host Response Hypothesis 30 years later |
09:00 – 10:00 | Thematic session : How can we improve engament of the heathcare team? |
09:00 – 09:15 | Multidisciplinar training: what are the challenges |
09:15 – 09:30 | Nursing team: what can be done in the long term |
09:30 – 09:45 | The patients perspective |
09:45 – 10:00 | Discussion |
10:00 – 10:30 | Clinical challenge: how to improve long term outcomes |
10:30 – 11:00 | BREAK |
11:00 – 11:40 | Oral presentations – Clinical science |
11:40 – 12:30 | Round table : Healhcare allies and the four pilars of sepsis management |
12:30 – 14:00 | LUNCH |
12:30 – 13:30 | Sponsors symposium |
14:00 – 15:10 | Thematic session : Thinking out of the box |
14:00 – 14:15 | Can we go greener in sepsis care? |
14:15 – 14:30 | Is the AI clinician our future? |
14:30 – 14:45 | Reverse innovation: how creative solutions in low-resource settings will alter ICU care for everyone |
14:45 – 15:10 | Discussion |
15:10 – 15:50 | Round table :What does ‘good’ quality improvement look like? Is it research? What ethical oversight does it require? |
15:50 – 16:15 | Plenary lecture Revisiting organ dysfunction |
16:15 – 16:45 | BREAK |
16:45 – 18:00 | GRAND FINALE (room 1) |
23/05 – Friday – Room 3 – Pediatrics and translational science | |
08:30 – 09:00 | plenaries in room 1 and 2 |
09:00 – 10:30 | Thematic session: Understanding the microbiota |
09:00 – 09:15 | The gut microbiome in critical illness |
09:15 – 09:30 | Empirical antibiotic therapy for sepsis: protect the anaerobic microbiota! |
09:30 – 09:45 | Microbiota-Gut-Brain axis in sepsis |
09:45 – 10:00 | Molecular insights of microbiota and innate lymphoid cell interactions |
10:00 – 10:30 | Discussion |
10:30 – 11:00 | BREAK |
11:00 – 11:40 | Oral presentations – translacional science |
12:00 – 12:30 | Plenary lecture: Sepsis trials in children – challenges and opportunities |
12:30 – 14:00 | LUNCH |
12:40 – 13:30 | Sponsors symposium |
14:00 – 14:45 | Thematic session: Improving sepsis outcomes |
14:00- 14::15 | Early recognition of sepsis in the community |
14:15 – 14:30 | Sepsis protocol: Does it matter? |
14:30 – 14:45 | Discussion |
14:45 – 15:15 | Clinical challenge: Still in shock: Navigating the next steps |
15:15 – 16:15 | Thematic session : Immunometabolism |
15:15 – 15:30 | Metabolic regulation of immune function |
15:30 – 15:45 | Rationale for cholesterol supplementation in sepsis |
15:45 – 16:00 | Platelets and lipid metabolism |
16:00 – 16:15 | Discussion |
16:15 – 16:45 | BREAK |
16:45 – 18:00 | GRAND FINALE (room 1) |